Stryker OptaBlate Bone Tumor RF Ablation System: Expanding Treatm
Cancer treatment continues to evolve beyond simply fighting disease. Today, healthcare providers are increasingly focused on improving quality of life, reducing pain, and helping patients maintain mobility throughout their treatment journey. One area receiving significant attention is the treatment of painful bone tumors and metastatic bone disease.
The Stryker OptaBlate Bone Tumor RF Ablation System was developed to help physicians perform minimally invasive bone tumor ablation procedures that may provide meaningful pain relief for patients suffering from painful bone lesions. As hospitals, cancer centers, interventional radiology departments, and spine programs continue expanding their treatment offerings, bone tumor ablation has become an important component of modern interventional oncology.
Healthcare facilities interested in the Stryker OptaBlate Bone Tumor RF Ablation System can view available inventory at:
Understanding Bone Tumor Ablation
Bone tumor ablation (BTA) is a minimally invasive procedure designed to treat painful bone tumors using radiofrequency energy. According to Stryker's patient education brochure, bone tumor ablation may help relieve pain caused by bone tumors while helping patients maintain their quality of life.
For many patients, painful bone lesions can dramatically affect everyday activities, mobility, and independence. Stryker notes that bone tumor ablation is supported by a growing body of evidence demonstrating its potential role in pain relief and quality-of-life improvement.
As a result, many healthcare facilities are evaluating technologies such as the Stryker OptaBlate Bone Tumor RF Ablation System to help meet the increasing demand for minimally invasive oncology treatments.
Why Bone Tumor Ablation Matters
According to information provided within the OptaBlate patient brochure, more than 1.9 million Americans are diagnosed with cancer annually, and approximately 280,000 of those patients develop bone metastases. These painful lesions can significantly affect mobility, comfort, and overall quality of life.
For patients who continue experiencing pain despite chemotherapy, radiation therapy, or other treatments, bone tumor ablation may provide an additional treatment option. Stryker specifically notes that BTA may be considered for patients who have already received treatment but still require pain relief.
Hospitals seeking to expand interventional oncology services often look for technologies that address these growing patient needs while supporting efficient procedural workflows.
Additional information about the Stryker OptaBlate Bone Tumor RF Ablation System is available here:
How the OptaBlate Procedure Works
The OptaBlate workflow is designed around image-guided access to the affected area. According to Stryker's procedure overview, physicians advance access cannulas into the treatment site and create pathways for the ablation probes. The probes are then positioned and connected before radiofrequency energy is delivered to ablate the painful tumor tissue.
The brochure explains that a high-frequency electrical current passes through the probe, heating and ablating the target tissue. In certain cases involving weight-bearing bone, physicians may also stabilize the area following treatment.
Because the procedure is minimally invasive, many patients may experience shorter recovery periods compared with more invasive treatment approaches.
Benefits Reported in the OptaBlate Patient Brochure
One reason facilities continue evaluating bone tumor ablation programs is the potential impact on patient outcomes. According to Stryker's patient brochure, bone tumor ablation may provide:
- Pain improvement with sustained long-term relief
- Greater range of motion
- Reduced use of analgesics
- Improved quality of life
- Short recovery times
- Return to normal activities within days for many patients
The brochure further states that many patients are able to return to normal activities, including bathing and showering, within just a few days following treatment.
These reported benefits continue driving interest in technologies such as the Stryker OptaBlate Bone Tumor RF Ablation System among hospitals and outpatient treatment centers.
Frequently Asked Questions
What is the Stryker OptaBlate Bone Tumor RF Ablation System?
The system is a specialized platform designed to perform minimally invasive bone tumor ablation procedures using radiofrequency energy to treat painful bone lesions.
Who may benefit from bone tumor ablation?
According to Stryker, bone tumor ablation may be an option for patients experiencing pain from bone tumors, including those who have already undergone chemotherapy or radiation therapy and continue experiencing symptoms.
Is bone tumor ablation minimally invasive?
Yes. The procedure uses image guidance and specialized access instruments to reach the treatment area through a minimally invasive approach.
How quickly can patients return to normal activities?
The OptaBlate brochure states that most patients are able to return to normal activities within a few days, although recovery may vary among individuals.
Why are hospitals investing in bone tumor ablation programs?
Hospitals continue expanding interventional oncology offerings because bone tumor ablation may help address pain, improve mobility, enhance quality of life, and provide additional treatment options for patients with painful bone lesions.
For facilities considering implementation, the Stryker OptaBlate Bone Tumor RF Ablation System provides a dedicated solution designed specifically for bone tumor ablation procedures.
Why Buy from Simon Medical, Inc.?
Simon Medical, Inc. specializes in advanced spine, neurosurgery, interventional radiology, and oncology technologies. Facilities purchasing capital equipment require more than a device. They need responsive support, product expertise, and immediate availability.
Hospitals and healthcare providers interested in expanding their interventional oncology capabilities can learn more about the Stryker OptaBlate Bone Tumor RF Ablation System at:
Whether your organization is developing a new interventional oncology program or adding advanced bone tumor ablation technology to an existing service line, the Stryker OptaBlate Bone Tumor RF Ablation System offers a minimally invasive treatment solution designed to help physicians address painful bone tumors.
Current availability can be viewed here:
References (AMA Style)
- Stryker Instruments. Better Days with Bone Tumor Ablation. Patient Education Brochure. IVS-OPTA-PTED-1668702 Rev 0. Copyright 2025.
- Stryker Instruments. Benefits of Bone Tumor Ablation and Procedure Overview. Better Days with Bone Tumor Ablation Patient Education Brochure.